An analysis of two large cohort studies finds that carriers of disease-causing variants within genes for three ...
Relatives with a pathogenic sarcomere gene variant have a lower risk for serious cardiac events than patients with hypertrophic cardiomyopathy but a higher risk than relatives without the variant.
Cardiomyopathy is a disease of the heart muscles which may cause them to become enlarged and inflamed. Inflamed muscles become stretched, weak, less efficient at pumping blood and less able to ...
Stress cardiomyopathy, also referred to as Takotsubo cardiomyopathy, transient apical ballooning or broken heart syndrome, is a disorder associated with transient left ventricular dysfunction.
BUFFALO, N.Y. – The American Heart Association has issued its first scientific treatment statement for pediatric cardiomyopathy, a rare disorder affecting the structure of the heart muscle that can ...
Capricor Therapeutics (CAPR) upgraded to Buy as FDA accepts HOPE-3 for Deramiocel in DMD cardiomyopathy; PDUFA Aug 22, 2026. Click here to read more.
Treating children with cardiomyopathy should be personalized based on the root cause, symptoms and progression of the condition in each child , according to a new American Heart Association scientific ...
Verywell Health on MSN
How caregivers can build the right care team for someone with ATTR-CM
Medically reviewed by Christopher Lee, MD Key Takeaways ATTR-CM often requires a team of healthcare providers, including cardiologists, specialists, and primary care doctors.Caregivers play an ...
AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.
Do you feel breathless and tired every now and then with slight physical activity? Something could be wrong with your heart muscle. Well, it may sound complicated but cardiomyopathy simply means a ...
Alnylam Canada ULC is pleased to announce it has received a positive recommendation from Canada's Drug Agency (CDA) for the public reimbursement of its RNAi therapeutic, AMVUTTRA®.1 In December 2025, ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果